Results 11 to 20 of about 13,230 (236)

“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism

Frontiers in Physiology, 2019
Background: “Pill-in-the-pocket” (PIP) treatment with type IC drugs for cardioversion of recent-onset atrial fibrillation (AF) has been recommended in guidelines.
Linling Li, Yanfei Ruan, Nian Liu, Qianqian Zhao, Mengxia Zhang, Xin Li, Song Zuo, Jiang Le, Kui Wu, Rong Bai, Changsheng Ma   +10 more
doaj   +2 more sources

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigated drug–drug interactions in patients with atrial fibrillation taking both a direct oral anticoagulant (DOAC) and an antiarrhythmic drug.
Victor Chien‐Chia Wu, Chun‐Li Wang, Yu‐Chang Huang, Hui‐Tzu Tu, Yu‐Tung Huang, Chang‐Fu Kuo, Shao‐Wei Chen, Kuo‐Chun Hung, Ming‐Shien Wen, Shang‐Hung Chang   +9 more
doaj   +2 more sources

Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report

Balkan Medical Journal, 2017
Background: Brugada syndrome is an inherited arrhythmogenic disease that may cause sudden cardiac death due to ventricular fibrillation in young adults. Brugada syndrome caused by propafenone intoxication has been noted rarely in the literature.
Mehmet Emre Arı, Filiz Ekici
doaj   +2 more sources

Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study

BMJ Open, 2019
Introduction Supraventricular arrhythmias contribute to haemodynamic compromise in septic shock. A retrospective study generated the hypothesis that propafenone could be more effective than amiodarone in achieving and maintaining sinus rhythm (SR ...
Martin Balik, Petr Waldauf, Michal Maly, Vojtech Matousek, Tomas Brozek, Jan Rulisek, Michal Porizka, Robert Sachl, Michal Otahal, Petr Brestovansky, Eva Svobodova, Marek Flaksa, Zdenek Stach, Jaroslav Pazout, Frantisek Duska, Ondrej Smid, Martin Stritesky   +16 more
doaj   +2 more sources

Propafenone efficacy in paroxysmal atrial fibrillation

Российский кардиологический журнал, 2004
Efficacy and safety of class IС antiarrhythmic agent, propafenone, was investigated in patients with paroxysmal atrial fibrillation (PAF), after single-dose load and during long-term preventive treatment.
V. V. Skibitsky, E. A. Kudryashov, N. A. Spiropulos, A. M. Kramskaya, Z. T. Sokaeva   +4 more
doaj   +2 more sources

Amiodarone Versus Propafenone to Treat Atrial Fibrillation after Coronary Artery Bypass Grafting: A Randomized Double Blind Controlled Trial

The Korean journal of thoracic and cardiovascular surgery, 2016
Background Atrial fibrillation (AF) is one of the most common complications after cardiac surgery. Several therapeutic and preventive strategies have been introduced for postoperative AF, but the treatment and prophylaxis of AF remain controversial.
Mohammad Hassan Nemati, Behrooz Astaneh
openalex   +3 more sources

Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages. [PDF]

J Arrhythm
Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
Faheem MSB, Khatri N, Cheema S, Zahid MR, Samadi S.   +4 more
europepmc   +2 more sources

Propafenone Induced Takotsubo Cardiomyopathy: A Mere Coincidence or A New Causal Relationship?

Düzce Tıp Fakültesi Dergisi, 2023
Propafenone is a class 1C antiarrhythmic drug that blocks sodium channels and is used in the treatment of arrhythmia. Because of its rapid effect on terminating paroxysmal episodes of atrial fibrillation, it can be used as a pill-in-the-pocket.
Adem Adar, Fahri Çakan
doaj   +1 more source

Development and Validation of a Simple and Sensitive ICP-MS Method for the Quantification of Elemental Impurities in Propafenone Hydrochloride Drug Substance

Jordan Journal of Pharmaceutical Sciences, 2023
Elemental impurities are substances present in drug products, excipients, or drug formulations. They may be formed by the presence of catalysts and environmental contaminants.
C. Raju, Subha Jhanavi A, B. Sivagami, N. Babu. M   +3 more
semanticscholar   +1 more source

A case of propafenone toxicity in the setting of dehydration and acute kidney injury. [PDF]

Glob Cardiol Sci Pract
Haddad E, Collins M.
europepmc   +3 more sources